Removes the expiration date on certain provisions relating to gender transition
- Introduced Dec 1, 2025
- In committee Jan 27, 2026
- Died
- Passed the House
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726…
Read the full title (104 words)
SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).
Every action
3 steps, oldest first, as the legislature records them.
- SenatePrefiled
- SenateS First Read
- CommitteeSecond Read and Referred S Families, Seniors and Health Committee · Senate Families, Seniors and Health
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it.
-
Rick BrattinR Primary sponsor · District 31
From Missouri's official records (www.senate.mo.gov), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.